Explore the EASD e-Learning platform for high-quality, up-to-date education in diabetes care and research.
- Tweets 10,691
- Following 1,767
- Followers 5,210
- Likes 6,061
Explore EASD e-Learning for high-quality, up-to-date #education in #diabetes care & #research.
✅Free access
✅Developed with world-leading experts
✅80+ CME-accredited modules
👉easd-elearning.eu
⚠️This account is no longer active. Follow @EASDnews for updates.
177
In the latest episode of our Gamechangers video series, Professor John Buse talks about a paper that he thinks will transform the way we manage #diabetes in years to come.
More Gamechangers episodes: easd-elearning.org/horizons/…
3
7
1,069
When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes.
Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria.
👉 easd-elearning.org/diabetes-…
ALT Destruction in Yemen
1
1
1,261
EASDelearning retweeted
We found a disruption to the seasonal pattern but no overall increase in the expected incidence of pediatric diabetes during the first three years of the COVID-19 pandemic in Ontario, Canada. @ADA_Pubs
Read Here➡️doi.org/10.2337/dc23-1794
2
4
963
EASDelearning retweeted
People with diabetes often encounter stigma which can adversely affect their health.
In @TheLancetEndo, authors call on the health community to endorse an evidence-based pledge to proactively challenge, & bring an end to, diabetes stigma & discrimination. hubs.li/Q02dRnmQ0
ALT Panel listing definitions of diabetes stigma and discrimination. Copyright: 2023 Elsevier Ltd. All rights reserved.
15
26
13,726
EASDelearning retweeted
These data define pathophysiological underpinnings of the tree structure, which has the potential to stratify #diabetes-related complications on the basis of routinely available variables & thereby expand the toolbox of precision diabetes diagnosis thelancet.com/journals/landi… #T2D
14
22
2,648
5 things we don't yet know...about #diabetes
Take a look at our video series with leading researchers talking about the big research questions that still need to be answered.
👉 easd-elearning.org/horizons/…
ALT Illustration of a microscope overlaid with text '5 things we don't yet know...about diabetes with Professor David Matthews'
1
3
1,139
EASDelearning retweeted
🚨🚨🚨Real‐world effectiveness and safety of oral semaglutide in people living with T2D: A nationwide multicentre retrospective observational study (ENDO2S‐RWD) Diabetes, Obesity and Metabolism dom-pubs.pericles-prod.liter… 🆓 @sociedadSEEN @SENefrologia @secardiologia @SEMERGENap
5
15
35
5,022
EASDelearning retweeted
Psychosocial care for people with diabetic neuropathy needs attention from both clinicians and researchers: a call for action. @ADA_Pubs
Read Here➡️doi.org/10.2337/dci23-0033
ALT Graphical Abstract
3
11
897
EASDelearning retweeted
Both continuous and intermittently scanned continuous glucose monitoring provide significant reductions in HbA1c compared to usual care, with no adverse impact on hypoglycemia. @ADA_Pubs
Read Here➡️doi.org/10.2337/dc23-1520
ALT Graphical Abstract
3
7
1,043
In our clip of the week, Professor John Buse discusses the paper that could change the future of screening for type 1 #diabetes. #T1D
Full clip on our site: easd-elearning.org/videos/ab…
329
EASDelearning retweeted
Our paper Inequalities the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database - @idasgupta7 @Nirantharakumar @sribellary @m_alikaramat @hazlehurst_j onlinelibrary.wiley.com/doi/…
7
12
1,172
When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes.
Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria 👉 easd-elearning.org/diabetes-…
ALT Destruction shown in Yemen
1
2
295
EASDelearning retweeted
#GLP1ReceptorAgonists are associated with lower incidences of adverse cardiovascular events and all-cause mortality in individuals with #NAFLD and #type2diabetes, compared with other glucose-lowering medications @DrAKrishnanMD #matchedcohortstudy tinyurl.com/2ef8unpm 🔓
1
11
32
3,816
EASDelearning retweeted
Everything you need when designing a study to investigate hepatic glucose uptake with FDG PET: getting us one step closer to unravelling the relationship between #diabetes and liver glucose metabolism tinyurl.com/2ksp24zv
5
20
2,181
EASDelearning retweeted
‘A blog to show case 10 folks or groups who –in my opinion-deserve a mention for their work which has helped many with #Diabetes through the year’
The “Top 10” for 2023
Thank you from me for all the work you all continue to do in challenging times
Link:
nhssugardoc.blogspot.com/202…
6
8
73
24,435
EASDelearning retweeted
Here, the brilliant Patrik Rorsman and team from @ocdem, @SahlgrenskaAcad and @OxfordBRC show the GLP-1 derivative GLP-1(9–36) to possess a direct inhibitory effect on glucagon secretion - an effect that was lost in alpha cells from human donors with #T2D
link.springer.com/article/10…
5
13
1,271
Clip of the week: Professor John Buse chooses a gamechanging paper that he thinks will transform the way we manage #diabetes in years to come.
Full clip: easd-elearning.org/videos/ab…
2
1
442
EASDelearning retweeted
Risk Factors for Young-Onset Dementia in the UK Biobank
15 risk factors identified, yep diabetes in there 😉 but a few interesting ones & considerations
@kamleshkhunti @scelee1 @ketandhatariya @EASDelearning @AskDrShashank @GoggleDocs @GeriSoc
jamanetwork.com/journals/jam…
1
16
1,149